Abbott India Limited (ABBOTINDIA): research summary

Price history, fundamentals, business-quality scores, DCF intrinsic value, shareholding, quarterly results and risk metrics for Abbott India Limited, explained in plain English.

• ▪Abbott India Limited is tracked in the Pharma & Healthcare sector of the NSE universe covered here.
• ▪ABBOTINDIA closed at ₹26,145.00 on 29 October 2026.
• ▪Over the past year the shares are down 12.0%, trading between ₹24,650.00 and ₹30,655.00.
• ▪Reported fundamentals show a net margin of 23.05%, debt to equity of 3.6.
• ▪Our transparent MaxGrade checklist scores it D (44/100) across momentum, growth, profitability and safety, using Pharma & Healthcare sector medians as the bar.
• ▪Annualised volatility over the past year is 20.77% with a maximum drawdown of -17.13% and a beta of 0.26 against NIFTY 50.

Other Pharma & Healthcare companies: Acutaas Chemicals, Ajanta Pharmaceuticals, Alkem Laboratories, Anthem Biosciences, Apollo Hospitals Enterprise, Aster DM Quality Care, Aurobindo Pharma, Biocon

Last traded values from 29 Oct 2026. Market opens at 9:15 IST.